Chin Hang Yiu

23PUBLICATIONS
56CO-AUTHORS
Public economics - publicly provided goodsPharmacogenomicsCancer therapy (excl. chemotherapy and radiation therapy)Toxicology (incl. clinical toxicology)Gene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|Oct 12, 2026
The cost of delay: foregone public expenditure savings from delayed adalimumab biosimilar listing in Australia's Pharmaceutical Benefits Scheme.

|Jul 28, 2026
Antipsychotic Drug Interactions and Short-Term Mortality Risk in People With Dementia: A National Cohort Study.

|May 30, 2026
Real-World Comparative Effectiveness and Safety of Immune Checkpoint Inhibitors in Advanced Renal Cell Carcinoma: A Systematic Review.

|May 17, 2026
Medication Management Strategies at Hospital Admission: A Systematic Review and Meta-Analysis.

|May 15, 2026
Ten-Year Public Expenditure Savings Associated with TNF Inhibitor Biosimilars under Australia's Pharmaceutical Benefits Scheme.

|May 14, 2026
Immunological Drug-Drug Interactions in Immune Checkpoint Inhibitor Therapy: Mechanisms, Clinical Evidence, and Artificial Intelligence.

Pageof 4

Frequent Collaborators

18 joint publications

Christine Y Lu

6 joint publications

Bella D Ianni

6 joint publications

Edwin Tan

5 joint publications

Richard O Day